Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXU2NE
|
||||
Drug Name |
4-tert-Butyl-N-[5-(2-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide
|
||||
Synonyms |
CHEMBL1907849
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H26FN3O2
|
||||
Canonical SMILES |
CN1C(=O)[C@@H](NC(=O)c2ccc(cc2)C(C)(C)C)N=C(c3ccccc3F)c4ccccc14
|
||||
InChI |
InChI=1S/C27H26FN3O2/c1-27(2,3)18-15-13-17(14-16-18)25(32)30-24-26(33)31(4)22-12-8-6-10-20(22)23(29-24)19-9-5-7-11-21(19)28/h5-16,24H,1-4H3,(H,30,32)/t24-/m1/s1
|
||||
InChIKey |
WMQHKRYEXNCHJH-XMMPIXPASA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.